about
Current Status of Hybrid PET/MRI in Oncologic ImagingA combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastomaImaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project.Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas.Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyGenomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Foxa2 identifies a cardiac progenitor population with ventricular differentiation potential.Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.The role of salvage reirradiation for malignant gliomas that progress on bevacizumab.Penumbra, the basis of neuroimaging in acute stroke treatment: current evidence.Segmentation of corpus callosum using diffusion tensor imaging: validation in patients with glioblastoma.NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics SignaturesCochlear implant failure: imaging evaluation of the electrode course.Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.Cerebral perfusion CT: technique and clinical applications.Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma.Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection.Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader StudyAcute calcific tendinitis of the longus colli: an imaging diagnosis.Bilateral iliopsoas hematoma: Case report and literature review.Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study.Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.Screening cervical spine CT in the emergency department, phase 3: increasing effectiveness of imaging.Improving imaging utilization through practice quality improvement (maintenance of certification part IV): a review of requirements and approach to implementation.Clinical predictors of abnormal magnetic resonance imaging findings in patients with asymmetric sensorineural hearing loss.T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower Grade Gliomas: A TCGA/TCIA Project.Perfusion Imaging in Neuro-Oncology: Basic Techniques and Clinical Applications.Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis.Idiopathic spinal cord herniation: an imaging diagnosis with a significant delay.High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
P50
Q26825265-B2E4CAA9-E385-4A14-89FF-A2588AF1F4E0Q30177343-B9D23A76-47A8-4E20-9560-199DA479BC2AQ30177647-36973D9A-61B5-4026-8565-C4B3AF3A7AB8Q30402988-E5D237F6-CD23-49BD-B7D3-94478C2A48F4Q30405581-1F1DCC52-0DC2-48FF-B4B9-B35C9453A497Q30413586-038B8A2D-44BE-44BF-A05A-33BD58E6415BQ30413713-207798C7-E4E2-4C31-B593-5B81089BFE86Q30414111-F7C49470-34A2-4E4A-95EF-03FAA053225DQ30653828-CD8666A6-D9C5-4775-B413-0C7C71F6D14AQ30839209-366C18DE-0813-4864-A8A4-D977C427BC8CQ30891381-792659E8-2F9B-4A65-8B99-8BAD719B404BQ31141368-CF37C183-F5A1-46A7-8A96-3AA0DEBA1BC0Q33511263-1E4CD40F-9F93-41F8-8F6F-CB7B6E7A5484Q33513788-4E0C4727-73BA-4319-ACC1-63B7162C4F7FQ34271501-0544547D-9C9F-44F7-B246-AA522C60073EQ34478588-CA3F46D9-AE86-4F09-BA87-5B7FCE9B84A6Q35093870-EAF5F7B7-0B52-40CB-AF55-B7BFF942B91CQ35170356-E563675B-6C61-4E35-9226-ED6492256F14Q35760475-91A6B727-DB96-4702-B826-0B95916781AAQ36069929-691B65CD-C451-4881-99A1-3D0634113718Q36390823-5C6F3657-43E9-463F-8FF5-A150D2713F36Q36463578-BFACC23D-301C-4DC1-9107-E378BAC077FCQ36943907-5C2C8812-289C-488C-848A-E16D7DED966AQ37073266-2AD967F2-5A0C-4BC0-B471-D5B11E6835A7Q37272806-5181FF36-002E-4773-B6C4-A6BAD381164EQ37474359-8532BD66-71B6-467C-BC46-0F2C7CC5F42CQ37697610-EE448CBE-D574-4CB5-9A4C-9701067AEA24Q38137491-E499BD21-F204-408E-99AA-0E88B8BD6EE2Q38198711-49DB2DF9-DCC0-4AA2-84AE-2D92418D807FQ38365433-A59E7335-2DD8-4C24-B572-CAD9F444DFD9Q38656588-1380832E-61FB-4068-9CB5-BAC2234FF64CQ38981037-5BA851C8-A4C1-4883-AFB4-2AA79B138A18Q39174318-CFAD41CE-2644-42FE-B035-2F1C3243183EQ39692548-02827797-80CE-47FB-9AD3-FB5027255063Q40052515-38EF7844-0EBA-4209-96FB-4B2D05E6FA6DQ41096808-B0438C82-1C16-4DA0-A267-689788B0389EQ41259845-C416CCDF-B49D-4E13-8DDA-B59D8BD4F3ECQ41770425-8E98CD75-8415-411B-82BE-89A501387C40Q42516186-F17E0297-5BED-4560-A1A7-E2D19FCE9079Q44652606-1251569F-37AD-4017-8150-4CD1771A1864
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4879-0457
@en
name
R Jain
@ast
R Jain
@en
R Jain
@nl
type
label
R Jain
@ast
R Jain
@en
R Jain
@nl
prefLabel
R Jain
@ast
R Jain
@en
R Jain
@nl
P106
P31
P496
0000-0002-4879-0457